|Assessment Status||Rapid Review Complete|
|Indication||For the symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief.|
|Rapid review commissioned||17/01/2011|
|Rapid review completed||29/03/2011|
|Rapid review outcome||Full Pharmacoeconomic Evaluation not Recommended|
Prucalopride (Resolor®) is to be reimbursed under the Community Drugs Schemes subject to conditions.